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BACKGROUND: Many studies showed the association between peripheral artery disease (PAD) and coronary artery disease (CAD). The ankle-
brachial index (ABI) was a simple, noninvasive, and not 
expensive test that showed high sensitivity and specificity 
in the diagnosis of PAD. Previous studies showed PAD 
correlation with the number of coronary artery lesions and 
higher complexity of the lesions. These correlations might 
contribute to worse cardiovascular outcomes, especially 
acute coronary syndrome (ACS) cases. Aim of this study 
is to evaluate the correlation abnormal ABI with the risk of 
ACS patients to have multivessel coronary artery lesions. 
METHODS: This was a retrospective analytical case 
control study. The data were taken from Dr. Wahidin 
Sudirohusodo  Hospital medical records from November 
2015  to  February  2016.  The  inclusion  criteria  were 
(>18 years old) patients with ACS who had underwent ABI 
examination and coronary angiography.       
RESULTS: The prevalence of patients with ST-elevation 
myocardial infarction (STEMI) was lower than non-ST 
elevation  ACS  (NSTE-ACS).  The  prevalence of patients 
with  abnormal  ABI  was  43.3%  and  patients with 
multivessel CAD was 65%. Male patients dominated the 
ACS population with 73.3%, about half of patients were 
smoking,  and  86.7%  had dyslipidemia. Patients  with 
abnormal ABI and multivessel disease had greater number 
than patients with normal ABI (p=0.025). Analysis with 
binary logistic regression model showed abnormal ABI 
(odd ratio [OR] 4.83; p=0.021) and male sex (OR 19.35; 
p=0.010) were associated with greater risk of multivessel 
CAD. 
CONCLUSION: An abnormal ABI is associated with 
greater risk of multivessel CAD in ACS patients.
KEYWORDS: ankle-brachial index, multivessel, coronary, 
acute coronary syndrome
Indones Biomed J. 2017; 9(1): 29-34
Abstract
Introduction
Atherosclerosis had become one of the leading cause of 
death in the world.(1) It has three main manifestations which 
involve coronary, cerebrovascular and peripheral arteries. 
Many studies had shown the association between these artery 
diseases, including the peripheral artery disease (PAD) and 
coronary artery disease (CAD).(2) The association between 
the PAD, high risk cardiovascular events and death also 
have been proven.(3) However, most patients with PAD 
were underdiagnosed because the asymptomatic clinical 
presentation and the physician’s awareness of the disease 
are relatively low.(4)
 The ankle-brachial index (ABI), as a noninvasive and 
simple modality, have high sensitivity and specificity for 
PAD diagnosis. ABI is not only useful as a diagnostic tool, 
but also is a powerful indicator of atherosclerotic disease 
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in other vascular bed and prognostic modality (increased 
cardiovascular morbidity/mortality with low ABI).(5,6)
 The previous studies have shown PAD correlation 
with the number of coronary artery lesions and the higher 
complexity of the lesions.(7,8,9) These correlations might 
contribute to worse cardiovascular outcomes, especially the 
acute coronary syndrome (ACS) cases. The aim of this study 
is to evaluate the correlation abnormal ABI with the risk of 
ACS patients to have multivessel coronary artery lesions.
Methods
This was a retrospective analytical case control study. The 
data were taken from Dr. Wahidin Sudirohusodo Hospital 
medical records since November 2015 until February 2016. 
In Dr. Wahidin Sudirohusodo Hospital, we performed ABI 
examination in patients with CAD. 
 ACS patients (>18 years old) who underwent coronary 
angiography and had the ABI examined previously were 
included. The exclusion criteria were patients with non-
atherosclerotic ACS, clinically suspected or history of 
congenital vascular abnormalities (e.g., coarctation aorta) 
and ABI value >1.4. The Health Research Ethics Board of 
the Hasanuddin University approved the research protocol 
(Number: 676/H04.8.4.5.31/PP36-KOMETIK/2016). 
 Patients were categorized as abnormal ABI if the 
ABI ≤0.9. Significant coronary stenosis was defined as the 
presence of coronary artery stenosis ≥50% of epicardial 
coronary artery, and we classified the patient into group 
with multivessel CAD if there were involvement of at least 
two main vessels and/or the left main coronary artery. 
 The differences characteristic data between two 
dependent (multivessel diseases) groups, nominal and 
numerical data were examined using Chi-Square and 
Independent   Sample  T-Test,  respectively.  A  binary 
logistic regression model was used to determine the 
relationship   between  independent  variable  and multivessel 
CAD. Significance was set at p<0.05. All calculations 
were performed  using  SPSS  version 18.0  software  for 
Windows.
The baseline characteristics of the study population are 
listed in Table 1 and Table 2. Sixty patients who were 
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hospitalized due to ACS at Dr. Wahidin Sudirohusodo 
Hospital, underwent coronary angiography. The prevalence 
Characteristic Category n %
ACS Diagnosis STEMI 27 45
NSTEMI 27 45
UAP 6 10
Abnormal ABI Yes 26 43.3
No 34 56.7
Multivessel CAD Yes 39 65
No 21 35
Sex Male 44 73.3
Female 16 26.7
Smoking Yes 32 53.3
No 28 46.7
Family History Yes 4 6.7
No 56 93.3
History of Stroke Yes 2 3.3
No 58 96.7
History of CAD Yes 25 41.7
No 35 58.3
Hypertension Yes 29 48.3
No 31 51.7
Dyslipidemia Yes 52 86.7
No 8 13.3
Diabetes Mellitus Yes 19 31.7
No 41 68.3
Number of Lesion Non-significant 5 8.3
1 Vessel Disease 16 26.7
2 Vessel Disease 15 25
3 Vessel Disease 24 40
Coronary Lesion Left Main 9 15
LAD 46 76.7
LCX 29 48.3
RCA 36 60
ACS: acute coronary syndrome; STEMI: ST-elevation myocardial infarction;  
NSTEMI: non-ST-elevation myocardial infarction; UAP: unstable angina; ABI: 
ankle-brachial index; CAD: coronary artery disease; LAD: left anterior 
descending; LCX: left circumflex atery; RCA: right coronary artery. 
Table 1. Baseline characteristics of categorical variables (n=60). 
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of patients with ST-elevation myocardial infarction (STEMI) 
(45%) was lower than non-ST elevation ACS (NSTE-ACS) 
(55%). ACS patients with abnormal ABI (43.3%) had 
lower numbers than the normal ones. Meanwhile patients 
with multivessel CAD had higher prevalence (65%). Male 
patients dominated the ACS population with 73.3% and 
about half of patients were smoking. The majority of the 
sample had dyslipidemia (86.7%). Left Anterior Descending 
(LAD) coronary artery was the most frequent coronary 
stenosis involved (76.7%).
 The mean age was 54.13 years old and mean 
blood pressure was 137.00/84.16 mmHg. The highest 
random blood glucose level was 433mg/dL. We found 
that  high  total  cholesterol  (mean=204.16mg/dL), 
low HDL (mean=39.76mg/dL), and high triglyceride 
(mean=154.13mg/dL) were consistent with high number of 
dyslipidemia prevalence. 
 Among several variables that had been evaluated, only 
abnormal  ABI  value showed significances. The prevalence 
of patients with multivessel CAD was found higher in 
patients with abnormal ABI than patients with normal ABI 
(p=0.025) (Table 3). Analysis with binary logistic regression 
model showed that abnormal ABI (odds ratio [OR] 4.83; 
p=0.021) and male sex (OR 19.35; p=0.010) were associated 
with a greater risk of multivessel CAD (Table 4).
Total ACS patients that had been hospitalized since 
November 2015 until February 2016 were 159 patients, but 
only 37.7% (60 patients) underwent coronary angiography 
due to financial problem/insurance and/or patient refused the 
procedure. The prevalence of STEMI in this study was quite 
Discussion
Characteristic Mean±SD Min Max
Age (years old) 54.13±9.07 32 73
Systolic Blood Pressure (mmHg) 137±28.48 80 240
Diastolic Blood Pressure (mmHg) 84.16±12.79 60 120
Random Blood Glucose (g/dL) 171.71±93.32 67 433
Total Choleserol (mg/dl) 204.16±52.34 99 401
HDL (mg/dl) 39.76±10.63 18 69
LDL (mg/dl) 139.9±51.37 45 368
Tryglyseride (mg/dl) 154.13±77.26 60 548
Table 2. Baseline characteristics of categorical variables (n=60).
high (45%), whereas in the US approximately 30% of ACS 
patients had STE-ACS (10), but the result was consistent 
with several previous studies in Makassar, Indonesia. Even 
in Brazil, the prevalence of patients with STEMI was higher 
(57%) than patients with NSTE-ACS (11). 
 The prevalence of multivessel CAD in ACS patients 
was higher than one vessel disease or non-significant stenosis 
as have been reported in many studies. Similar finding is 
also proved in our study that patients with abnormal ABI 
had higher prevalence of multivessel CAD than those with 
normal index (p=0.025).
 In high risk CAD patients (and also already known 
CAD), the prevalence of abnormal ABI is higher than those 
in general population, which is up to 42% (12,13), in our 
study the prevalence was 43.3%. The data in sub-analysis of 
The Global Registry of Acute Coronary Events (GRACE) 
study, the prevalence of PAD was only 9.7% out of 41,108 
patients admitted with ACS.(14) It was likely that PAD 
was underdiagnosed in the study because the PAD patients 
included were only those in whom diagnosis had already 
been made, whereas about half of patients with PAD are 
asymptomatic. Another study analyzed the presence of PAD 
by measuring the ABI in patient with ACS, the study only 
identified 26% patients.(15) This finding almost 50% lower 
than ours, this is probably because our study had no upper 
limit of ages. As other study reported, PAD or abnormal 
ABI was more frequent in older group patients.(16) Another 
reason that made our prevalence of abnormal ABI relatively 
high was the measurement of ABI. We used lower ABI 
(more patients would be identified), because it has better 
sensitivity and it was a good predictor for PAD.(17)
 Sex (male) had been established in another study to be 
associated with the presence of multivessel CAD (18), but 
in our study its statistically significances showed only with 
another variable in binary logistic regression. This might be 
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Variable OR p
Abnormal ABI 4.83 0.02
Hypertension 1.59 0.48
Smoking 0.30 0.20
Dyslipidemia 0.58 0.59
Diabetes Mellitus 0.94 0.93
Age 0.93 0.10
Sex 19.35 0.01
*Binary logistic regression test, significant if p < 0.10
Table 4. Analysis comparison of abnormal ABI and control variable with multivessel CAD.
Yes No
Sex Male 31 13 0.14
Female 8 8
Smoking Yes 21 11 0.91
No 18 10
Hypertension Yes 20 9 0.53
No 19 12
Dyslipidemia Yes 33 19 0.52
No 6 2
Diabetes Mellitus Yes 13 6 0.71
No 26 15
History of Hypertension Yes 24 12 0.74
No 15 9
History of Diabetes Mellitus Yes 12 5 0.57
No 27 16
Family History Yes 3 1 0.66
No 36 20
History of Stroke Yes 2 0 0.29
No 37 21
History of Dyslipidemia Yes 3 1 0.66
No 36 20
History of CAD Yes 17 8 0.68
No 22 13
Abnormal ABI Yes 21 5 0.02
No 18 16
*Pearson chi-square test, significant if p <0.05
Variable
Multivessel
Category p
Table 3. Association between independent and control variable to dependent variable (n=6).
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